Search

everythinglearnresearchcommunity

for

Search:↓

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Mast cells might contribute to hair loss by causing skin thickening.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

Finasteride shows promise for female hair loss, but more research needed.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Scalp reduction can improve hair distribution in certain baldness cases but requires careful patient selection and understanding of facial structure.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Age, gender, and hair loss affect scalp characteristics differently in young Caucasian adults.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Skin aging reflects overall body aging and can indicate internal health conditions.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Puerariae Flos extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

No cure for female pattern hair loss, but various effective treatments exist.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

Extracorporeal shock waves significantly improve hair growth in women with female pattern hair loss.